News

Now that the infection prevention and control community has had some time to learn about the Food and Drug Administration (FDA)s concerns regarding positive-displacement needleless connectors and the possible link to bloodstream infections (BSIs) and patient mortality, the question seems to be, now what?

A recent report from Textiles Intelligence in the United Kingdom indicates that smart textiles and nanotechnology will enhance the benefits of personal protective equipment (PPE) used to protect workers from occupational exposures, hazardous materials, and pathogens that trigger infectious diseases.

Introduction of the PCV-7 vaccine to prevent invasive pneumococcal disease (IPD) has led to a shift in the types of bacteria causing hemolytic uremic syndrome, an important cause of acute kidney failure in children, reports a study in the August issue of the Pediatric Infectious Disease Journal.

The Florida Times-Union is reporting today on the case of Jean Law, a nurse on staff at Baptist Medical Center-South in Jacksonville, Fla. who contracted a bacterial infection and had to have both legs and eight fingers amputated because staff at the facility allegedly failed to diagnose her septic condition quickly enough.

Researchers describe a novel device that utilizes immunosensor and bio-optical technology to detect M. tuberculosis antigen (Ag85B) in cough and demonstrate its use under field conditions during a pilot study in an area of high TB incidence.

Unilife Corporation has launched Unitract.com to support the commercial release of its Unitract 1 mL clinical safety syringes.

Researchers show that public education campaigns regarding hand hygiene are effective in altering individual hand hygiene habits during the peak periods of influenza transmission.

When Staphylococcus aureus is isolated in urine, it is thought to usually represent hematogenous spread. Because such spread might have special clinical significance, Shingo Chihara and colleagues evaluated predictors and outcomes of S. aureus bacteriuria among patients with S. aureus bacteremia.

Researchers have discovered a novel mechanism in Salmonella that affects its virulence and its susceptibility to antibiotics by changing its production of proteins in a previously unheard of manner. This allows Salmonella to selectively change its levels of certain proteins to respond to inhospitable conditions.